216 related articles for article (PubMed ID: 7748963)
21. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
22. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
[TBL] [Abstract][Full Text] [Related]
23. Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance.
Bahia DM; Yamamoto M; Chauffaille Mde L; Kimura EY; Bordin JO; Filgueiras MA; Kerbauy J
Haematologica; 2001 Aug; 86(8):801-6. PubMed ID: 11522535
[TBL] [Abstract][Full Text] [Related]
24. The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML.
del Cañizo MC; Almeida J; San Miguel JF; Orfao A; Gonzalez M; Lopez Borrasca A
Ann Hematol; 1994 May; 68(5):233-6. PubMed ID: 8018763
[TBL] [Abstract][Full Text] [Related]
25. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
[TBL] [Abstract][Full Text] [Related]
26. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
Bradstock K; Matthews J; Benson E; Page F; Bishop J
Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of co-expression of aberrant antigens in acute leukemia: a retrospective cohort study in Makah Al Mukaramah, Saudi Arabia.
Abdulateef NA; Ismail MM; Aljedani H
Asian Pac J Cancer Prev; 2014; 15(1):221-7. PubMed ID: 24528030
[TBL] [Abstract][Full Text] [Related]
29. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
Zelezníková T; Babusíková O
Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802
[TBL] [Abstract][Full Text] [Related]
31. [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].
Reinhardt D; Langebrake C; Creutzig U; Vormoor J; Brune C; Thorwesten M; Ingiliz P; Hrusak O; Dworzak M; Griesinger F
Klin Padiatr; 2002; 214(4):179-87. PubMed ID: 12165899
[TBL] [Abstract][Full Text] [Related]
32. Expression of unusual immunophenotype combinations in acute myelogenous leukemia.
Reading CL; Estey EH; Huh YO; Claxton DF; Sanchez G; Terstappen LW; O'Brien MC; Baron S; Deisseroth AB
Blood; 1993 Jun; 81(11):3083-90. PubMed ID: 8499643
[TBL] [Abstract][Full Text] [Related]
33. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
[TBL] [Abstract][Full Text] [Related]
34. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis.
Del Cañizo MC; Galende J; Mota A; Orfao A; Martinez A; Almeida J; San Miguel JF
Leuk Res; 1997 Jul; 21(7):651-6. PubMed ID: 9301686
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic, cytogenetic and clinical features of 192 AML patients in China.
Tong H; Lu C; Zhang J; Liu Z; Ma Y
Clin Exp Med; 2009 Jun; 9(2):149-55. PubMed ID: 19205620
[TBL] [Abstract][Full Text] [Related]
36. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
37. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia].
Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362
[TBL] [Abstract][Full Text] [Related]
38. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
Dunphy CH; Tang W
Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160
[TBL] [Abstract][Full Text] [Related]
39. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
40. CD34+/CD33+ blast cells: correlation with FAB subtypes.
Rigolin GM; Lanza F; Ferrari L; Castoldi G
Leuk Lymphoma; 1995; 18 Suppl 1():43-8. PubMed ID: 7496354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
